Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Denali Therapeutics Inc (DNLI)

Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines PR Newswire - Thu Oct 19, 2023

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

DNLI : 21.74 (-1.23%)
FHTX : 5.44 (-6.85%)
MRNA : 117.07 (+0.97%)
OMGA : 2.07 (-8.00%)
SANA : 5.35 (-2.19%)
MCRB : 0.7010 (-2.91%)
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded...

DNLI : 21.74 (-1.23%)
FHTX : 5.44 (-6.85%)
MRNA : 117.07 (+0.97%)
OMGA : 2.07 (-8.00%)
SANA : 5.35 (-2.19%)
MCRB : 0.7010 (-2.91%)
Flagship Pioneering Named to Fortune's 2023 "Change the World" List PR Newswire - Wed Sep 27, 2023

/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...

DNLI : 21.74 (-1.23%)
FHTX : 5.44 (-6.85%)
MRNA : 117.07 (+0.97%)
OMGA : 2.07 (-8.00%)
SANA : 5.35 (-2.19%)
MCRB : 0.7010 (-2.91%)
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer PR Newswire - Mon Sep 11, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...

DNLI : 21.74 (-1.23%)
FHTX : 5.44 (-6.85%)
MRNA : 117.07 (+0.97%)
OMGA : 2.07 (-8.00%)
SANA : 5.35 (-2.19%)
MCRB : 0.7010 (-2.91%)
Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner PR Newswire - Tue Aug 29, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that pharma and healthcare leader David Khougazian is joining as...

DNLI : 21.74 (-1.23%)
FHTX : 5.44 (-6.85%)
MRNA : 117.07 (+0.97%)
OMGA : 2.07 (-8.00%)
SANA : 5.35 (-2.19%)
MCRB : 0.7010 (-2.91%)
Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Ampersand Biomedicines, a company programming smarter medicines that act...

DNLI : 21.74 (-1.23%)
FHTX : 5.44 (-6.85%)
MRNA : 117.07 (+0.97%)
OMGA : 2.07 (-8.00%)
SANA : 5.35 (-2.19%)
MCRB : 0.7010 (-2.91%)
Author
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential MarketBeat - Thu May 18, 2023

These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.

DNLI : 21.74 (-1.23%)
RARE : 40.96 (-0.39%)
SRPT : 154.20 (-1.63%)
PFE : 27.83 (-1.38%)
EXEL : 22.15 (-0.45%)
MRNA : 117.07 (+0.97%)
UTHR : 317.05 (-0.61%)
BIIB : 228.82 (-1.27%)
SNY : 48.54 (-2.12%)
LLY : 906.71 (-0.84%)
Why Shares of Denali Therapeutics Are Up Monday Motley Fool - Mon May 15, 2023

Analysts maintained their buy ratings on the clinical-stage biotech company.

DNLI : 21.74 (-1.23%)
Cellarity Strengthens Executive Leadership Team Business Wire - Tue Apr 11, 2023

Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are discovered, announced today the appointments of John Leaman, M.D., M.B.A., as Chief Financial Officer...

IMPL : 0.0400 (-27.27%)
SELB : 0.8812 (-8.00%)
MDGN : 5.57 (+3.15%)
DNLI : 21.74 (-1.23%)
EVLO : 0.0001 (unch)
FHTX : 5.44 (-6.85%)
MRNA : 117.07 (+0.97%)
OMGA : 2.07 (-8.00%)
SANA : 5.35 (-2.19%)
MCRB : 0.7010 (-2.91%)
Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed Business Wire - Tue Mar 7, 2023

Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating programmable medicines that are safer, more tolerable, and effective by acting at the...

DNLI : 21.74 (-1.23%)
EVLO : 0.0001 (unch)
FHTX : 5.44 (-6.85%)
MRNA : 117.07 (+0.97%)
OMGA : 2.07 (-8.00%)
SANA : 5.35 (-2.19%)
MCRB : 0.7010 (-2.91%)

Barchart Exclusives

Is This Copper Mining Stock a Buy for Its Fat Dividend? Barchart - Tue Jul 2, 6:30PM CDT
Southern Copper has a higher dividend yield compared to other copper mining companies. However, its valuations are also on the higher side, making a closer examination of the risk-reward necessary for prospective investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot